2017
DOI: 10.1016/j.bprint.2017.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Simulation of cortico-cancellous bone structure by 3D printing of bilayer calcium phosphate-based scaffolds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 52 publications
(20 citation statements)
references
References 34 publications
0
20
0
Order By: Relevance
“…(53,54) Several examples exist in the literature where calcium phosphates have been printed in a vertical gradient with camphene,(55) poly(propylene fumarate),(56) and other scaffold materials(23) to generate biochemical distributions and physical architectures that mimic features of natural bone tissue – e.g., the transition from cortical to cancellous bone. (57) Literature is much sparser, however, on the creation of calcium phosphate gradients in combination with growth factor gradients. Ahlfeld et al showed one case in which a two-channel plotting system was used to fabricate biphasic scaffolds containing a calcium phosphate cement (CPC) component and a vascular endothelial growth factor (VEGF)-loaded hydrogel component.…”
Section: Fabricating Spatiotemporal Growth Factor Patternsmentioning
confidence: 99%
“…(53,54) Several examples exist in the literature where calcium phosphates have been printed in a vertical gradient with camphene,(55) poly(propylene fumarate),(56) and other scaffold materials(23) to generate biochemical distributions and physical architectures that mimic features of natural bone tissue – e.g., the transition from cortical to cancellous bone. (57) Literature is much sparser, however, on the creation of calcium phosphate gradients in combination with growth factor gradients. Ahlfeld et al showed one case in which a two-channel plotting system was used to fabricate biphasic scaffolds containing a calcium phosphate cement (CPC) component and a vascular endothelial growth factor (VEGF)-loaded hydrogel component.…”
Section: Fabricating Spatiotemporal Growth Factor Patternsmentioning
confidence: 99%
“…Whatever process is used to fabricate a scaffold, it must be able to process bioresorbable and biodegradable materials so that they can form a scaffold with a large surface area and high porosity. 3-D printing (3-DP) and fused deposition modeling (FDM) are two examples of rapid prototyping technologies that allow for the creation of scaffolds that are porous and are able to copy living tissue's microstructure [23]. 3-DP allows for the processing of bioresorbable scaffolds for applications relating to tissue engineering specifically [74].…”
Section: Scaffoldsmentioning
confidence: 99%
“…In regard to tissue engineering of a particular cartilage, although implanting artificial matrices, growth factors, perichondrium, and periosteum can initiate the formation of cartilaginous tissue in osteochondral and chondral defects in synovial fluids, the results vary considerably from patient to patient [16]. A successful scaffold is one that fits the anatomical defects defined from clinical imaging data, while also having a design that is porous and that can balance load bearing and biofactor delivery requirements [17][18][19][20][21][22][23][24][25][26][27][28][29][30]. For these designs, the global image design database is created from a computed tomography (CT) or magnetic resonance (MR) image of a patient.…”
Section: Introductionmentioning
confidence: 99%
“…Historical progress of this field was heavily dependent upon cell‐free printing using hard bone‐like materials like ceramics (HA/β‐tricalcium phosphate), bioglass‐ceramic composites and polymers (PCL), which will not be discussed here as many good reviews have already covered those aspects (Bose, Vahabzadeh, & Bandyopadhyay, ; Jariwala et al, ; Li, Chen, Fan, & Zhou, ; Wen et al, ). A major limitation is that such ceramic‐based scaffolds (some of which have been listed in Figure ) require post‐fabrication processing such as high temperature sintering or dissolution in organic solvents (Almela et al, ; Roohani‐Esfahani, Newman, & Zreiqat, ) to confer stability on constructs and hence do not support live‐cell printing. Such scaffolds only allow top seeding of cells, which often leads to non‐uniform cell distribution and heterogeneous differentiation, hence failing to imitate true in vivo conditions (Holmes et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…Abbreviations: PCL, poly(caprolactone); PLA, polylactic acid; GelMA, gelatin methacryloyl; PEGDA, poly(ethylene glycol) diacrylate; hMSCs, human mesenchymal stem cells; hAFSCs, human amniotic fluidderived stem cells; HA, hydroxyapatite; HUVECs, human umbilical vein endothelial cells; BMP, bone morphogenetic protein; VEGF, vascular endothelial growth factor; β-TCP, beta tricalcium phosphate, TGF, transforming growth factor, RGD, Arg-Gly-Asp [Colour figure can be viewed at wileyonlinelibrary.com] those aspects (Bose, Vahabzadeh, & Bandyopadhyay, 2013;Jariwala et al, 2015;Li, Chen, Fan, & Zhou, 2016;Wen et al, 2017). A major limitation is that such ceramic-based scaffolds (some of which have been listed in Figure 1) require post-fabrication processing such as high temperature sintering or dissolution in organic solvents (Almela et al, 2017;Roohani-Esfahani, Newman, & Zreiqat, 2016) to confer stability on constructs and hence do not support live-cell printing.…”
Section: Introductionmentioning
confidence: 99%